KeyZell has been one of the companies invited to participate on April 28th in the Madrid Capital e-Health cluster (link). The event aims to bring together representatives of startups and multinationals with the most innovative projects in the health and biotechnology sector.
Tony Solanes, CBO of the company, was in charge of talking about the actions that KeyZell is developing. In his presentation, he highlighted the role of artificial intelligence in early diagnosis and the establishment of personalized treatments for patients with breast and lung cancer.
This was an opportunity to present Keyzell’s professional activity in the application of its artificial intelligence engines for the definition of personalized treatments based on patients’ clinical and genetic data. Tony Solanes also highlighted the revolutionary implementation of cutting-edge technology for the early diagnosis of cancer in patients with difficult access to medical services because they are in isolated rural areas.
The new edition of the Madrid Capital e-Health cluster has been held successfully and the event has been consolidated as an effective instrument of public-private collaboration to facilitate the coordinated efforts of administrations, entrepreneurs, investors, universities and research centers, ensuring the synergy of actions and collaborating in the orientation of public policies and the allocation of resources in the field of e-Health.
The event has been broadcast live via streaming and can be viewed here.
